Tag: Polar Capital
Pfizer keeping tabs on AstraZeneca for potential $100 billion deal
US drug-maker Pfizer Inc has prepared a third offer to acquire Britain's AstraZeneca Plc, after refusing Pfizer’s earlier approaches for a takeover.
According to the...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
